Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Bone Marrow Diseases
Description
Diseases involving the BONE MARROW. MeSH
Hierarchy View
Subtype Terms (5)
Bone Marrow Failure Disorders
42 drugs (26 approved, 16 experimental)
Bone Marrow Neoplasms
2 experimental drugs
Myelodysplastic-Myeloproliferative Diseases
58 drugs (41 approved, 17 experimental)
Myelodysplastic Syndromes
681 drugs (254 approved, 427 experimental)
Myeloproliferative Disorders
292 drugs (173 approved, 119 experimental)
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (15)
Phase 1 Indicated Drugs (18)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (23)
Organization Involved with Phase 2 Indications (17)
Organization Involved with Phase 1 Indications (17)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
